Clinical Trials Sponsored by Bharat Biotech International Limited

Total 23 results

Bharat Biotech International Limited

Recruiting

The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants (Rota5DCHILE)

Rotavirus Infection of Children

Chile
Bharat Biotech International Limited

Recruiting

To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131) (Hillchol131)

Cholera

India
Bharat Biotech International Limited

Completed

Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine

Chikungunya

India
Bharat Biotech International Limited

Completed

Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose

COVID-19 Respiratory Infection

India
Bharat Biotech International Limited

Active, not recruiting

Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers (Nasal154PH3)

COVID-19 Respiratory Infection

India
Bharat Biotech International Limited

Active, not recruiting

A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131). (Hillchol)

Cholera

India
Bharat Biotech International Limited

Completed

Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19

SARS-CoV Infection

India
Bharat Biotech International Limited

Completed

A Trial Using Double-Bolus THR-100 Versus Streptokinase (THR-100)

Acute Myocardial Infarction

India
Bharat Biotech International Limited

Completed

BBV152/BBV154 Heterologus Prime-Boost Study (BBV152BBV154)

Corona Virus Infection

India
Bharat Biotech International Limited

Completed

COVAXIN in a Pediatric Cohort (COVAXIN-Peds)

SARS-CoV2 Infection

India
Bharat Biotech International Limited

Completed

Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam

Rotavirus Gastroenteritis

Vietnam
Bharat Biotech International Limited

Completed

Safety and Immunogenicity of BBV121 (Zika)

Zika Virus Infection

India
University of Chile
Bharat Biotech International Limited

Recruiting

The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E

Rotavirus Gastroenteritis

Chile
Bharat Biotech International Limited
Indian Council of Medical Research

Completed

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers (BBV152)

COVID-19 | SARS-CoV-2 Infection

India
Bharat Biotech International Limited
Georgia Institute for Clinical Research, LLC

Completed

To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus (ROTAVAC5C)

Rotavirus Gastroenteritis
Bharat Biotech International Limited
PATH; Ministry of Science and Technology, India

Unknown

A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E (ROTAVAC)

Viral Gastroenteritis Due to Rotavirus

India
Bharat Biotech International Limited
Indian Council of Medical Research; Iqvia Pty Ltd

Active, not recruiting

An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Covid19 | SARS-CoV Infection

India
University of Maryland, Baltimore
Wellcome Trust; Bharat Biotech International

Recruiting

Trivalent Salmonella Conjugate Vaccine (TSCV)

Trivalent Salmonella Conjugate Vaccine (TSCV)

Mali
Institute of Clinical Research and Clinical Trial...
Bharat Biotech International Limited

Unknown

Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam

Rotavirus Infections

Vietnam
Institute of Clinical Research and Clinical Trial...
Bharat Biotech International Limited

Completed

Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly

Rabies

Vietnam
Centre for Infectious Disease Research in Zambia
Children's Hospital Medical Center, Cincinnati; PATH; Bharat Biotech International... and other collaborators

Completed

Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia (ROTAVAC)

Diarrhea | Diarrhea Rotavirus

Zambia
Bharat Biotech International Limited
Indian Council of Medical Research; National Institutes of Health (NIH); Stanford... and other collaborators

Completed

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

Diarrhea

India
Tangent Data
Stanley Medical Research Institute; MediStat Ltd.; PCI pharma services (formerly... and other collaborators

Unknown

Estradiol as add-on to Antipsychotics (EST-S-02)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorders

Moldova, Republic of

Clinical Trials Sponsored by Bharat Biotech International Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations